Cargando…

Analysis of the factors motivating HCV-infected patients to accept interferon therapy

BACKGROUND: The aims of this study were to analyze factors motivating the acceptance of interferon (IFN) therapy and to clarify the prevalence of oral mucosal diseases in hepatitis C virus (HCV)-infected Japanese patients treated with IFN. FINDINGS: A total of 94 HCV-infected patients who were admit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagao, Yumiko, Sata, Michio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500275/ https://www.ncbi.nlm.nih.gov/pubmed/22932002 http://dx.doi.org/10.1186/1756-0500-5-470

Ejemplares similares

Dental problems delaying the initiation of interferon therapy for HCV-infected patients
por: Nagao, Yumiko, et al.
Publicado: (2010)

Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseases
por: Nagao, Yumiko, et al.
Publicado: (2012)

Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection
por: Nagao, Yumiko, et al.
Publicado: (2014)

Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan
por: Nagao, Yumiko, et al.
Publicado: (2010)

Effect of oral care gel on the quality of life for oral lichen planus in patients with chronic HCV infection
por: Nagao, Yumiko, et al.
Publicado: (2011)

Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study
por: Nagao, Yumiko, et al.
Publicado: (2012)

Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals
por: Nagao, Yumiko, et al.
Publicado: (2016)

Disappearance of Oral Lichen Planus After Liver Transplantation for Primary Biliary Cirrhosis and Immunosuppressive Therapy in a 63-year-Old Japanese Woman
por: Nagao, Yumiko, et al.
Publicado: (2014)

Valine, a Branched-Chain Amino Acid, Reduced HCV Viral Load and Led to Eradication of HCV by Interferon Therapy in a Decompensated Cirrhotic Patient
por: Kawaguchi, Takumi, et al.
Publicado: (2012)

Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?
por: Zicca, Emilia, et al.
Publicado: (2014)

Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients
por: Yamasaki, Kazumi, et al.
Publicado: (2012)

A retrospective case-control study of hepatitis C virus infection and oral lichen planus in Japan: association study with mutations in the core and NS5A region of hepatitis C virus
por: Nagao, Yumiko, et al.
Publicado: (2012)

Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV-infected patients with chronic liver disease and thrombocytopenia
por: Kawaguchi, Takumi, et al.
Publicado: (2019)

Interferon-λ in HCV Infection and Therapy
por: Pagliaccetti, Nicole E., et al.
Publicado: (2010)

Effect of Oral Care Gel for Burning Mouth Syndrome in a Patient with Hepatitis C: A Case Report
por: Nagao, Yumiko, et al.
Publicado: (2017)

False-seronegative HCV infection motivated by interference with cryoglobulins
por: Recio Comí, Gemma, et al.
Publicado: (2021)

Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin
por: Toyoda, Hidenori, et al.
Publicado: (2012)

HCV antigen instead of RNA testing to diagnose acute HCV in patients treated in the Dutch Acute HCV in HIV Study
por: Hullegie, Sebastiaan J., et al.
Publicado: (2017)

Altered Thymic Function during Interferon Therapy in HCV-Infected Patients
por: Beq, Stephanie, et al.
Publicado: (2012)

Sofosbuvir/velpatasvir in treatment-experienced HCV-infected patients – short report
por: Piekarska, Anna, et al.
Publicado: (2020)

Peg-interferon Plus Ribavirin Combination Therapy in HCV Mono-infected and HCV/HIV Co-infected Patients in Iran
por: Hesamizadeh, Khashayar, et al.
Publicado: (2019)

Effect of interferon-free therapy on cognition in HCV and HCV/HIV infection: A pilot study
por: Kleefeld, Felix, et al.
Publicado: (2017)

Acceptability of bone antiresorptive therapy among HIV-infected adults at different stages of antiretroviral therapy
por: Taras, Jillian, et al.
Publicado: (2014)

Feasibility and acceptability of motivational interviewing to promote colorectal cancer screening among average risk Chinese older adults
por: Chan, Dorothy N.S., et al.
Publicado: (2023)

Use of Direct-Acting Antivirals for the Treatment of Hepatitis C Virus-Associated Oral Lichen Planus: A Case Report
por: Misaka, Kenji, et al.
Publicado: (2016)

Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies
por: Lau, Jillian S. Y., et al.
Publicado: (2020)

Oral lichen planus and HCV infection
por: Tenório, Jefferson R., et al.
Publicado: (2020)

Prevalence of HCV genotypes in district Mardan
por: Afridi, Suliman Qadir, et al.
Publicado: (2013)

Total and High Molecular Weight Adiponectin and Hepatocellular Carcinoma with HCV Infection
por: Sumie, Shuji, et al.
Publicado: (2011)

Project ECHO Revisited: Propensity Score Analysis And HCV Treatment Outcomes
por: Page, Kimberly, et al.
Publicado: (2019)

Efficacy of Sovodak in the Management of Patients Co-infected with HIV/HCV
por: Somi, Mohammad Hossein, et al.
Publicado: (2020)

Response to peginterferon plus ribavirin and subsequent retreatment with telaprevir-based triple therapy in a patient with chronic lymphocytic leukaemia and chronic HCV genotype 1b infection
por: Christensen, Stefan, et al.
Publicado: (2014)

Dermatomyositis as a complication of interferon-α therapy: a case report and review of the literature
por: Shiba, Hideyuki, et al.
Publicado: (2014)

Regulation of the Interferon Response by lncRNAs in HCV Infection
por: Valadkhan, Saba, et al.
Publicado: (2018)

Treatment of Recurrent Hepatocellular Carcinoma with Sorafenib in a HIV/HCV Co-Infected patient in HAART: A Case Report
por: De Nardo, Pasquale, et al.
Publicado: (2012)

Toxoplasma gondii, HBV, and HCV co‐infection and their correlation with CD4 cells among Iranian HIV‐positive patients
por: Bazmjoo, Ahmadreza, et al.
Publicado: (2023)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report
por: Popescu, Cristina, et al.
Publicado: (2011)

Study of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani population
por: Mansoor, Atika, et al.
Publicado: (2013)

Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection
por: Sung, Pil Soo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_113o7u5j83ocdhplmgb5p3pd90